Improving Pain Management and Opioid Safety for Patients With Cirrhosis
Cirrhosis, Liver
About this trial
This is an interventional health services research trial for Cirrhosis, Liver focused on measuring liver diseases, cirrhosis, liver, implementation science, strategies, evaluation, behavioral intervention
Eligibility Criteria
Inclusion Criteria:
- All participants must be over 18 years of age and fluent in English
- Must have a diagnosis of cirrhosis
- Must be receiving care at UPMC hepatology clinics
- Must have chronic pain lasting at least 3 months
Exclusion Criteria:
- Participants will be excluded if they are younger than 18 years of age or are unable to provide informed consent for any reason
- Participants will be excluded if they had a prior liver transplantation or have a limited life expectancy of less than 6 months
Sites / Locations
- University of Pittsburgh Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
LEAP Intervention Arm
Usual Care
Half of the recruited patients (anticipate 20) will participate in 12 weekly sessions to teach self-pain management tools and skills. In addition to alternating weeks of group and individual sessions, participants will track their activities using the LEAP workbook provided during the first meeting, as tracking is a key component of most pain-self management interventions and is intended to address self-regulation. All patients can continue to use other pain management strategies ("usual care") in order to mimic real-life conditions.
Half of the recruited patients (anticipated 20) will receive usual care under the control arm of this study. These participants will not receive the intervention.